1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG
Professor
Pharmacy Clinical & Admin Sci
Phone (405) 271-6878 x47296
Office O'Donoghue Research Bldg., 1122 NE 13th St., Ste. 4417, OKC 73117
Email jamie-miller@ouhsc.edu
Publications & Presentations
- 101. Capino A C, Dannaway D C, Miller J L. Metabolic Acidosis with Ophthalmic Dorzolamide in a Neonate. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2016; 21 : 256-9
102. Capino A C, Miller J L, Hughes K M, Miller M J, Johnson P N. Caregiver perception, self-efficacy, and knowledge of methadone tapers for children with iatrogenic opioid abstinence syndrome. Journal of Pharmacy Technology. 2016; 32 : 104-15
103. Johnson P N, Miller J L, Ranallo C. Dosing of Vasopressin in Critically Ill Children: Implications for Medication Safety. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2016; 17 : 277-8
104. Golding C L, Miller J L, Gessouroun M R, Johnson P N. Ketamine Continuous Infusions in Critically Ill Infants and Children. The Annals of pharmacotherapy. 2016; 50 : 234-41
105. Boucher E A, Burke M M, Johnson P N, Klein K C, Miller J L. Minimum requirements for core competency in pediatric pharmacy practice. Journal of Pediatric Pharmacology and Therapeutics. 2015; 20 : 458-61
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 1. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2024.
2. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2024.
3. American Society of Health-System Pharmacists. Fellow of American Society of Health-System Pharmacists. Date: 2024.
4. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.
5. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.
Education
- 1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.
2. Degree: BS. Trevecca Nazarene University. Date: 2002.